Category: Technology (2)

Category: Technology (2)

Technology Partners

BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

Read the original release at BioCentriq.com NEWARK, NJ, June 6, 2023 – BioCentriq®, a strategic...
Kytopen
June 06, 2023
Technology Publications

Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy Discovery, Development, and Manufacturing

Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy...
Kytopen
May 24, 2023
Technology Team

MIT News: 3 Questions: Cullen Buie on a new era for cell therapies

Read the original post on MIT News
Kytopen
February 07, 2023
Technology Partners

Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines

The two companies will collaborate to combine industry-leading technologies and tackle the...
Kytopen
February 07, 2023
Technology

Kytopen awarded NIH grant of up to $2M to unlock the power of engineered Natural Killer (NK) cells via Flowfect® platform

NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral...
Kytopen
June 15, 2021
Technology

Rapid discovery and manufacture of next-generation cell therapies

MIT spin-out company Kytopen has engaged Cambridge Consultants to co-develop the first Flowfect™...
Kytopen
January 20, 2021
Technology

Flowfect™ Tx Revealed

Kytopen, an MIT spin-out company, and Cambridge Consultants, part of Capgemini, announce the...
Kytopen
October 28, 2020